Suppr超能文献

依那普利和尼群地平对早期肾病的血压正常的I型糖尿病患者运动性蛋白尿的影响。

Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.

作者信息

Heinemann L, Janicke I, Bender R, Berger M, Sawicki P T

机构信息

Department of Metabolic Diseases and Nutrition, Heinrich-Heine-University Düsseldorf, Germany.

出版信息

Horm Metab Res. 1996 Oct;28(10):549-52. doi: 10.1055/s-2007-979850.

Abstract

Based on animal experiments it has been proposed that antihypertensive agents may differentially influence albuminuria through their divergent effects on glomerular haemodynamics or glomerular sieving properties and may beneficially influence the progression of diabetic nephropathy even without an effect on blood pressure. However, to date this hypothesis has not been tested in normotensive patients with diabetic nephropathy. The main aim of this study was therefore to investigate the effects of the administration of two antihypertensive agents on albuminuria during rest and exercise. The study consisted of 3 x 3 randomised, cross-over periods with five days double blind administration of enalapril (E: 2.5 mg bid), nitrendipine (N: 5 mg bid) and placebo (P) on 18 Type 1 normotensive (blood pressure < 140/90 mmHg) diabetic patients with incipient diabetic nephropathy (albuminuria 30-300 mg/24 h, normal glomerular filtration rate, diabetes duration > 6 years and presence of diabetic reinopathy. The aim of this study was to investigate the effect of enalapril and nitrendipine on blood pressure values and albuminuria during exercise challenge (bicycle ergometry: 20 min at 75 W and 20 min at 100 W) in comparison to the placebo. Albumin excretion rates during pre-exercise rest (mean +/- SD; E: 6.2 +/- 6.0; N: 7.1 +/- 8.0; P: 7.7 +/- 7.0 mg/mmol creatinine) and during exercise (E: 8.7 +/- 9.4; N: 8.2 +/- 8.2; P: 11.1 +/- 11.4 mg/mmol creatinine) were comparable between the drugs and not significantly different after administration of placebo. Blood pressure values were significantly different between the medications (systolic blood pressure: p = 0.0269; diastolic blood pressure: p = 0.0021, ANOVA for repeated measurements). There were no significant correlations between blood pressure values and albuminuria at any time. In normotensive patients with incipient diabetic nephropathy low-dose administration of enalapril, nitrendipine and placebo does not result in clear cut differences in albuminuria.

摘要

基于动物实验,有人提出抗高血压药物可能通过对肾小球血流动力学或肾小球滤过特性的不同影响而对蛋白尿产生不同影响,并且即使对血压没有影响,也可能对糖尿病肾病的进展产生有益影响。然而,迄今为止,这一假设尚未在血压正常的糖尿病肾病患者中得到验证。因此,本研究的主要目的是调查两种抗高血压药物在静息和运动期间对蛋白尿的影响。该研究包括3个3期随机交叉试验阶段,对18例1型血压正常(血压<140/90 mmHg)且患有早期糖尿病肾病(蛋白尿30 - 300 mg/24 h,肾小球滤过率正常,糖尿病病程>6年且存在糖尿病视网膜病变)的糖尿病患者进行为期5天的双盲给药,药物分别为依那普利(E:2.5 mg,每日两次)、尼群地平(N:5 mg,每日两次)和安慰剂(P)。本研究的目的是调查与安慰剂相比,依那普利和尼群地平在运动挑战(自行车测力计:75 W运动20分钟,100 W运动20分钟)期间对血压值和蛋白尿的影响。运动前静息时(平均值±标准差;E组:6.2±6.0;N组:7.1±8.0;P组:7.7±7.0 mg/mmol肌酐)和运动期间(E组:8.7±9.4;N组:8.2±8.2;P组:11.1±11.4 mg/mmol肌酐)的白蛋白排泄率在各药物组之间具有可比性,给予安慰剂后无显著差异。各药物之间的血压值存在显著差异(收缩压:p = 0.0269;舒张压:p = 0.0021,重复测量方差分析)。在任何时候,血压值与蛋白尿之间均无显著相关性。在血压正常的早期糖尿病肾病患者中,低剂量给予依那普利、尼群地平及安慰剂对蛋白尿无明显差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验